Drugs / SPARC1316
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02041221 | Jan → Nov 2014 | asthma | Sun Pharma Advanced Research Company Limited | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SPARC1316 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02041221 ↗ |